Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Critical Care Medicine

Standard of Care: The ICU Rescue Mission

At a Glance

The first 24 hours of cardiogenic shock treatment focus on stabilizing the patient through a combination of opening blocked arteries, IV medications to boost blood pressure, and mechanical heart pumps. The primary goal is to restore vital blood flow while allowing the heart muscle to rest.

When a patient enters the ICU with cardiogenic shock, the medical team launches a high-intensity, multi-pronged rescue mission. The goal of the first 24 hours is to stabilize the “pump,” protect the organs, and reverse the downward spiral of shock [1][2].

You will hear constant alarms and beeps in the ICU. Try to remember that machines beep for many reasons—often just to signal a minor adjustment or that the patient moved. Not every alarm means a life-threatening emergency.

Step 1: Fix the “Plumbing” (Revascularization)

If the shock was caused by a heart attack (AMI-CS), the first priority is reopening the blocked artery that caused the damage [3].

  • PCI (Percutaneous Coronary Intervention): Doctors usually use a catheter to place a stent in the “culprit” artery to restore blood flow [4].
  • Emergency Bypass (CABG): In rare or complex cases, a surgeon may perform emergency heart surgery to bypass the blockages [5].

Step 2: Support the “Squeeze” (Vasoactive Medications)

You will see several IV bags running into your loved one, while their heart rate and blood pressure are continuously tracked on large screens above the bed. These IV bags contain powerful medications often called “vasoactives” [1].

  • Inotropes (e.g., Dobutamine, Milrinone): These act like a “booster” for the heart muscle, helping it squeeze more effectively to push blood out [6][7].
  • Vasopressors (e.g., Norepinephrine): These tighten the blood vessels to raise blood pressure and ensure blood reaches the brain [7][8].

The Double-Edged Sword: While these drugs are life-saving, they are also stressful for the heart. They can make the heart beat too fast, cause irregular rhythms (arrhythmias), or make the heart muscle demand more oxygen than it can get [9][10]. Doctors use the lowest dose possible to get the job done [11].

Step 3: Mechanical Circulatory Support (MCS)

When medications aren’t enough, doctors use machines to physically take over the work of the heart. This is called Mechanical Circulatory Support (MCS) [12].

Device How it Works Primary Goal
IABP (Intra-Aortic Balloon Pump) A balloon in the main artery (aorta) that inflates and deflates with the heartbeat [13]. Helps blood flow into the heart’s own arteries and slightly eases the heart’s workload [14].
Impella (Heart Pump) A tiny pump inserted directly into the heart’s left ventricle [15]. Actively “unloads” the heart by pulling blood out and pushing it into the body, letting the heart muscle rest [16].
VA-ECMO (Extracorporeal Membrane Oxygenation) A large machine that pulls blood out of the body, adds oxygen, and pumps it back in [14]. Supports both the heart and the lungs. It provides the most support but is the most complex [13].

The Risks of Mechanical Support: These machines are life-saving but are intended as temporary bridges, not long-term solutions. They carry high risks of severe complications, including major bleeding, stroke, and restricted blood flow to the legs (limb ischemia). This is why the medical team is constantly looking for signs that the heart is recovering, so they can “wean” the patient off these supports as quickly and safely as possible.

Success Metrics in the First 24 Hours

How do doctors know if the treatment is winning? They look for three key signs:

  1. Lactate Clearance: Lactate (a waste product of starving cells) should start to drop. If it decreases significantly within the first 6–24 hours, it is a very positive sign that organs are getting blood [17][18].
  2. Urine Output: When the kidneys receive enough blood, they begin to produce urine again—at least 0.5 mL for every kilogram of the patient’s weight per hour [19].
  3. Hemodynamic Goals: Doctors track a “Cardiac Power Output” (CPO) score, which measures the overall strength of the heart’s pumping capacity while on support [20].

The first 24 hours are about stabilization. Once the “downward spiral” stops, the team can begin to plan for recovery and eventually “weaning” the patient off these supports [12][21].

Common questions in this guide

How do doctors treat cardiogenic shock in the ICU?
Treatment usually involves a three-step rescue process: opening blocked arteries, giving IV medications to boost blood pressure, and using mechanical heart pumps to support blood flow while the heart rests.
What is the purpose of vasoactive medications in the ICU?
Vasoactive medications like inotropes and vasopressors help the heart squeeze stronger and tighten blood vessels to raise blood pressure. Doctors carefully use the lowest effective dose because these drugs can put extra stress on the heart.
What does an Impella or ECMO machine do?
These are mechanical circulatory support devices that temporarily take over the pumping work of the heart. An Impella is a tiny pump inside the heart, while ECMO supports both the heart and lungs by adding oxygen to the blood and pumping it through the body.
How does the ICU team know if the cardiogenic shock treatment is working?
Doctors look for signs that the body's organs are receiving enough blood. Highly positive signs include decreasing lactate levels in blood tests, an increase in urine output, and improved heart pumping strength.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If a heart attack caused this, was the procedure (PCI) successful in opening the blocked artery?
  2. 2.Which vasoactive medications is my loved one on, and are the doses currently being 'weaned' (lowered) or increased?
  3. 3.Which mechanical support device (Impella, ECMO, or IABP) is being used, and why was that specific one chosen for them?
  4. 4.Are you seeing improvements in 'lactate clearance' and urine output over the last 12 hours?
  5. 5.What are the risks of bleeding or limb issues with the current machines, and how are we monitoring for those?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Nonischemic Causes of Cardiogenic Shock.

    Wilcox SR

    Emergency medicine clinics of North America 2019; (37(3)):493-509 doi:10.1016/j.emc.2019.03.007.

    PMID: 31262417
  2. 2

    Predictors of In-Hospital Mortality in Isolated Total Anomalous Pulmonary Venous Connection.

    Elamry E, Alkady HM, Menaissy Y, Abdalla O

    The heart surgery forum 2019; (22(3)):E191-E196 doi:10.1532/hsf.2415.

    PMID: 31237541
  3. 3

    Cardiogenic Shock After Acute Myocardial Infarction: A Review.

    Samsky MD, Morrow DA, Proudfoot AG, et al.

    JAMA 2021; (326(18)):1840-1850 doi:10.1001/jama.2021.18323.

    PMID: 34751704
  4. 4

    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.

    Thiele H, Akin I, Sandri M, et al.

    The New England journal of medicine 2018; (379(18)):1699-1710 doi:10.1056/NEJMoa1808788.

    PMID: 30145971
  5. 5

    Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction.

    Davierwala PM, Leontyev S, Verevkin A, et al.

    Circulation 2016; (134(17)):1224-1237 doi:10.1161/CIRCULATIONAHA.115.021092.

    PMID: 27777292
  6. 6

    Vasopressor use in cardiogenic shock.

    Levy B, Klein T, Kimmoun A

    Current opinion in critical care 2020; (26(4)):411-416 doi:10.1097/MCC.0000000000000743.

    PMID: 32487842
  7. 7

    [Use of vasopressors and inotropics in cardiogenic shock].

    Lemm H, Dietz S, Janusch M, Buerke M

    Herz 2017; (42(1)):3-10 doi:10.1007/s00059-016-4525-2.

    PMID: 28101622
  8. 8

    Circulatory shock in adults in emergency department.

    Pannu AK

    Turkish journal of emergency medicine 2023; (23(3)):139-148 doi:10.4103/2452-2473.367400.

    PMID: 37529784
  9. 9

    Inotropic therapies in heart failure and cardiogenic shock: an educational review.

    DesJardin JT, Teerlink JR

    European heart journal. Acute cardiovascular care 2021; (10(6)):676-686 doi:10.1093/ehjacc/zuab047.

    PMID: 34219157
  10. 10

    Inotropes and vasopressors use in cardiogenic shock: when, which and how much?

    Levy B, Buzon J, Kimmoun A

    Current opinion in critical care 2019; (25(4)):384-390 doi:10.1097/MCC.0000000000000632.

    PMID: 31166204
  11. 11

    Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device.

    Rohm CL, Gadidov B, Ray HE, et al.

    Cardiovascular revascularization medicine : including molecular interventions 2021; (31()):71-75 doi:10.1016/j.carrev.2020.12.001.

    PMID: 33309042
  12. 12

    Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association.

    Geller BJ, Sinha SS, Kapur NK, et al.

    Circulation 2022; (146(6)):e50-e68 doi:10.1161/CIR.0000000000001076.

    PMID: 35862152
  13. 13

    Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review.

    Wong ASK, Sin SWC

    Annals of translational medicine 2020; (8(13)):829 doi:10.21037/atm-20-2171.

    PMID: 32793674
  14. 14

    Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock.

    Pappalardo F, Schulte C, Pieri M, et al.

    European journal of heart failure 2017; (19(3)):404-412 doi:10.1002/ejhf.668.

    PMID: 27709750
  15. 15

    How to Manage Temporary Mechanical Circulatory Support Devices in the Critical Care Setting: Translating Physiology to the Bedside.

    Rao P, Katz D, Hieda M, Sabe M

    Heart failure clinics 2020; (16(3)):283-293 doi:10.1016/j.hfc.2020.03.001.

    PMID: 32503752
  16. 16

    Beyond one-size-fits-all in cardiogenic shock: impella, extracorporeal membrane oxygenation or tailored use of mechanical circulatory support?

    Rob D, Belohlavek J

    Current opinion in critical care 2024; (30(4)):371-378 doi:10.1097/MCC.0000000000001165.

    PMID: 38872369
  17. 17

    Lactate Clearance Is Associated With Improved Survival in Cardiogenic Shock: A Systematic Review and Meta-Analysis of Prognostic Factor Studies.

    Marbach JA, Stone S, Schwartz B, et al.

    Journal of cardiac failure 2021; (27(10)):1082-1089 doi:10.1016/j.cardfail.2021.08.012.

    PMID: 34625128
  18. 18

    Arterial Lactate in Cardiogenic Shock: Prognostic Value of Clearance Versus Single Values.

    Fuernau G, Desch S, de Waha-Thiele S, et al.

    JACC. Cardiovascular interventions 2020; (13(19)):2208-2216 doi:10.1016/j.jcin.2020.06.037.

    PMID: 33032708
  19. 19

    Biventricular Impella (Bi-Pella) in Refractory Cardiogenic Shock: The First Case from the Middle East.

    Almejren A, Alenezi A

    Case reports in medicine 2021; (2021()):6676339 doi:10.1155/2021/6676339.

    PMID: 34335787
  20. 20

    Cardiac power output index to define hemodynamic response to Impella support in cardiogenic shock.

    Sern Lim H

    The International journal of artificial organs 2022; (45(7)):598-603 doi:10.1177/03913988221100278.

    PMID: 35578554
  21. 21

    Cardiogenic Shock.

    Thiele H, Hassager C

    The New England journal of medicine 2026; (394(1)):62-77 doi:10.1056/NEJMra2312086.

    PMID: 41467651

This page explains ICU treatments for cardiogenic shock for educational purposes only. Always consult the critical care team regarding your loved one's specific medical care, device risks, and recovery plan.

Get notified when new evidence is published on Cardiogenic shock.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.